Who is the CEO of Everlab?

Marc Hermann leads Everlab as CEO. Co-founder of Foodspring, a D2C fitness food brand which was acquired by Mars.

Where is Everlab headquartered?

Everlab is headquartered in Melbourne, Australia. The company has a team of 101-500 people.

What does Everlab do?

Everlab operates in the AI in Healthcare sector. An AI-powered health platform for personalized, preventive healthcare and longevity. To provide a comprehensive and personalized approach to preventive health, using advanced diagnostics and AI to detect diseases early, optimize wellbeing, and extend healthspan.

When was Everlab founded?

Everlab was founded in 2023. It is based in Melbourne, Australia.

Who is the CEO of Everlab?

Marc Hermann is the CEO of Everlab. The company was founded in 2023.

What funding stage is Everlab at?

Everlab is currently at the Growth Stage stage.

How many employees does Everlab have?

Everlab has approximately 101-500 employees.

Everlab

Category: AI in Healthcare

An AI-powered health platform for personalized, preventive healthcare and longevity. Everlab was founded in 2023. The company is led by Marc Hermann. Based in Melbourne, Australia. Team size: 101-500. Total funding raised: $83 million. Latest round: Series A. Key investors include Airtree Ventures, Left Lane Capital, Plural, b2venture, AfterWork Ventures, TEN13, Flying Fox Ventures, Pat Cummins.

Founded: 2023
Headquarters: Melbourne, Australia
Team size: 101-500
Total funding: $83 million

Value proposition

To provide a comprehensive and personalized approach to preventive health, using advanced diagnostics and AI to detect diseases early, optimize wellbeing, and extend healthspan.

Products and solutions

Annual subscription-based memberships, Comprehensive health diagnostics (blood tests, whole-body MRIs, DEXA scans, etc.), Personalized health optimization plans, Ongoing support from doctors, dietitians, and personal trainers, Everlab app with a digital health avatar

Unique value

Everlab's uniqueness lies in its holistic, clinician-led service combined with a proprietary AI platform. It creates a 'digital health avatar' for each member, offering a hyper-personalized and data-driven approach to preventive care.

Target customer

Health-conscious individuals, particularly middle-aged men and women, interested in proactive health management and longevity.

Industries served

Healthcare, Wellness and Fitness, HealthTech, Artificial Intelligence

Technology advantage

The company's advantage stems from its AI-powered platform that analyzes complex health data, automates clinical summaries, and identifies early risk markers. This streamlines physician workflows, making personalized and preventive care more scalable and efficient. The subscription-based model provides a recurring revenue stream.

How they differentiate

Everlab differentiates itself by offering a comprehensive and clinician-led preventative health service that uses AI to analyze a wide range of diagnostics, including full-body MRIs, blood tests, and genetic analysis. This allows for early detection of diseases and personalized health plans. Their model aims to be more scalable and accessible than competitors, moving beyond a single-test focus to a continuous health management platform.

Main competitors

Prenuvo, Edifice Health, Deep Longevity

Key partnerships

National pathology and radiology networks for diagnostic testing, Airtree Ventures (Series A lead), Plural (Series A investor), Left Lane Capital (seed + Series A), b2venture (pre-seed + Series A), Pat Cummins (angel investor)

Notable customers

While specific customer names are not public, the company has highlighted that it has saved lives on a weekly basis through early detection of serious health conditions.

Major milestones

Raised AU$65M Series A led by Airtree Ventures at ~$500M valuation (June 2026)., Revenue grew 10x in 11 months following seed round., Now serves 20,000+ patients with 40,000+ consultations., Expanded to 180+ clinicians and 1,850+ healthcare provider locations., Expanded engineering team from <10 to 25., 114 urgent life-saving findings in 2025., Expanding into UK market.

Growth metrics

One in four members receive abnormal results from their health assessments. For 2.5% of members, the findings are life-changing, such as the detection of blocked arteries, brain aneurysms, or early-stage cancers with low survival rates if detected later.

Market positioning

Everlab is positioned as a premium provider in the preventative health and longevity market. It targets health-conscious individuals, particularly those at risk of chronic diseases, who are proactive about their long-term well-being. By using technology to reduce costs, they aim to make their comprehensive services available to a broader audience than what has traditionally been reserved for the ultra-wealthy.

Geographic focus

Everlab is headquartered in Melbourne, Australia, and is currently focused on the Australian market. However, with its latest funding, the company is planning for international expansion into competitive markets, likely targeting regions with high demand for preventative healthcare like North America and Europe.

Patents and IP

Not publicly available

About Marc Hermann

Co-founder of Foodspring, a D2C fitness food brand which was acquired by Mars.

Latest news about Everlab

San Francisco-based Ever has secured 31 million dollars in Series A funding led by Eclipse to scale its AI-native EV marketplace. By integrating machine learning into battery health and local charging

More AI in Healthcare companies

Official website: https://www.everlab.com/